Macular Degeneration (Amd) and Diabetic Retinopathy (Dr) Drugs Market - Global Industry Analysis and Forecast 2015 - 2021

Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs

Market - Global Industry Analysis and Forecast 2015 - 2021

Persistence Market Research

Macular Degeneration (AMD) and Diabetic

Retinopathy (DR) Drugs Market - Global

Industry Analysis and Forecast 2015 - 2021

Persistence Market Research

1

Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs

Market - Global Industry Analysis and Forecast 2015 - 2021

Persistence Market Research Released New Market Report on “Macular Degeneration (AMD)

and Diabetic Retinopathy (DR) Drugs Market - Global Industry Analysis and Forecast

2015 - 2021”.

Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central

visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults

with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due

to complications in diabetes.

Request Full TOC: http://www.persistencemarketresearch.com/toc/5879

The market of macular degeneration drugs can be segmented on the basis of available and upcoming

drugs, such as Lucentis, Eylea, Avastin, Squalamine, Conercept, Lampalizamab and others. Moreover,

the market can also be segmented on the basis of stage and type of AMD, such as early AMD, late AMD,

dry AMD and wet AMD. Similarly, the market of diabetic retinopathy is also segmented on the basis of

available and under pipeline products, such as Lucentis, Optina, Iluvien, Betamethazone, Ozurdex and

others. The market can be also segmented on the basis of geography, such as, North America, Europe,

Asia-Pacific and Rest of the World (RoW). The North American region is the most lucrative market, owing

to large number of elderly population in the U.S. However, European and Asia-Pacific regions are

considered as the most promising markets in the upcoming period.

Buy Full Report:...